Lo, D., Anderson, D., Song, M., Leopardi, F., Strobert, E., Wang, R., … Kirk, A. (2014). Selective Targeting of Activated LFA-1 Using a Novel Antibody, AL-579, in Nonhuman Primate Kidney Transplantation. In Transplantation (Vol. 98, pp. 26–26). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00007890-201407151-00079

Lo, D., D. Anderson, M. Song, F. Leopardi, E. Strobert, R. Wang, K. Reimann, T. Springer, and A. Kirk. “Selective Targeting of Activated LFA-1 Using a Novel Antibody, AL-579, in Nonhuman Primate Kidney Transplantation.” In Transplantation, 98:26–26. Ovid Technologies (Wolters Kluwer Health), 2014. https://doi.org/10.1097/00007890-201407151-00079.

Lo D, Anderson D, Song M, Leopardi F, Strobert E, Wang R, et al. Selective Targeting of Activated LFA-1 Using a Novel Antibody, AL-579, in Nonhuman Primate Kidney Transplantation. In: Transplantation. Ovid Technologies (Wolters Kluwer Health); 2014. p. 26–26.

Lo, D., et al. “Selective Targeting of Activated LFA-1 Using a Novel Antibody, AL-579, in Nonhuman Primate Kidney Transplantation.” Transplantation, vol. 98, Ovid Technologies (Wolters Kluwer Health), 2014, pp. 26–26. Crossref, doi:10.1097/00007890-201407151-00079.

Lo D, Anderson D, Song M, Leopardi F, Strobert E, Wang R, Reimann K, Springer T, Kirk A. Selective Targeting of Activated LFA-1 Using a Novel Antibody, AL-579, in Nonhuman Primate Kidney Transplantation. Transplantation. Ovid Technologies (Wolters Kluwer Health); 2014. p. 26–26.